Stolina M - Search Results

1

Analysis of the kinetics of osteoclastogenesis in arthritic rats.

Schett G, Stolina M, Bolon B, Middleton S, Adlam M, Brown H, Zhu L, Feige U, Zack DJ. Schett G, et al. Among authors: stolina m. Arthritis Rheum. 2005 Oct;52(10):3192-201. doi: 10.1002/art.21343. Arthritis Rheum. 2005. PMID: 16200623 Free article.

2

Regulatory effects of osteoprotegerin on cellular and humoral immune responses.

Stolina M, Guo J, Faggioni R, Brown H, Senaldi G. Stolina M, et al. Clin Immunol. 2003 Dec;109(3):347-54. doi: 10.1016/j.clim.2003.09.001. Clin Immunol. 2003. PMID: 14697750

3

Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.

Schett G, Middleton S, Bolon B, Stolina M, Brown H, Zhu L, Pretorius J, Zack DJ, Kostenuik P, Feige U. Schett G, et al. Among authors: stolina m. Arthritis Rheum. 2005 May;52(5):1604-11. doi: 10.1002/art.21021. Arthritis Rheum. 2005. PMID: 15880601 Free article.

4

RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.

Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, Geng Z, Middleton S, Brown H, Pretorius J, Schett G, Bolon B, Feige U, Zack D, Kostenuik PJ. Stolina M, et al. J Bone Miner Res. 2005 Oct;20(10):1756-65. doi: 10.1359/JBMR.050601. Epub 2005 Jun 6. J Bone Miner Res. 2005. PMID: 16160733 Free article.

5

RANKL inhibition: from mice to men (and women).

Stolina M, Kostenuik PJ, Dougall WC, Fitzpatrick LA, Zack DJ. Stolina M, et al. Adv Exp Med Biol. 2007;602:143-50. doi: 10.1007/978-0-387-72009-8_18. Adv Exp Med Biol. 2007. PMID: 17966399 Review.

6

Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responses.

Stolina M, Dwyer D, Ominsky MS, Corbin T, Van G, Bolon B, Sarosi I, McCabe J, Zack DJ, Kostenuik P. Stolina M, et al. J Immunol. 2007 Dec 1;179(11):7497-505. doi: 10.4049/jimmunol.179.11.7497. J Immunol. 2007. PMID: 18025194

7

The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.

Stolina M, Bolon B, Middleton S, Dwyer D, Brown H, Duryea D, Zhu L, Rohner A, Pretorius J, Kostenuik P, Feige U, Zack D. Stolina M, et al. J Clin Immunol. 2009 Mar;29(2):158-74. doi: 10.1007/s10875-008-9238-8. Epub 2008 Aug 26. J Clin Immunol. 2009. PMID: 18726678

8

The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis.

Stolina M, Bolon B, Dwyer D, Middleton S, Duryea D, Kostenuik PJ, Feige U, Zack DJ. Stolina M, et al. Biomarkers. 2008 Nov;13(7):692-712. doi: 10.1080/13547500802651911. Biomarkers. 2008. PMID: 19096963

9

Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.

Schett G, Stolina M, Dwyer D, Zack D, Uderhardt S, Krönke G, Kostenuik P, Feige U. Schett G, et al. Among authors: stolina m. Arthritis Rheum. 2009 Sep;60(9):2644-54. doi: 10.1002/art.24767. Arthritis Rheum. 2009. PMID: 19714640 Free article.

10

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.

Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea D, Pacheco E, Van G, Bolon B, Feige U, Zack D, Kostenuik P. Stolina M, et al. Arthritis Res Ther. 2009;11(6):R187. doi: 10.1186/ar2879. Epub 2009 Dec 11. Arthritis Res Ther. 2009. PMID: 20003323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters